Potential Replacements For Warfarin

BMI View: Stroke prevention is a major therapeutic area in which drugmakers are looking to launch the next blockbuster. The size of the market and the risks associated with the standard warfarin therapy means drugmakers able to successfully launch a replacement therapy will enjoy significant financial returns. Moreover, given that the 'one-size fits all' approach is obsolete, competing drugs will retain a share of this massive market by differentiating through mechanisms of action and dosage regimens, among other

To read the full article, please choose one of the following options: